Skyview Partners, LLC – Trademark Portfolio
Entity Type: 16
Skyview Partners, LLC owns a portfolio of 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ADVERIO, MERGE IN, SKYVIEW1, NEXTLEVEL, and XCCELERATE. Of these, 16 are registered and 2 are pending. The portfolio spans 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 36 (Insurance & Financial). Headquartered in Wayzata, MN.
Suite 120
294 Grove Lane East
Wayzata, MN 55391
Showing of trademarks Trademarks
Trademark Classifications
Skyview Partners, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Skyview Partners, LLC have?
Skyview Partners, LLC has 19 U.S. trademarks filed with the USPTO. Of these, 16 registered, 2 pending, 1 abandoned.
What trademark classes does Skyview Partners, LLC file in?
Skyview Partners, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are Skyview Partners, LLC's most well-known trademarks?
Skyview Partners, LLC's registered trademark portfolio includes well-known marks such as ADVERIO, MERGE IN, SKYVIEW1, NEXTLEVEL, and XCCELERATE. These are among 16 currently registered trademarks in the portfolio.
What is Skyview Partners, LLC's trademark registration success rate?
Skyview Partners, LLC has a 94% trademark registration rate, with 16 out of 17 resolved applications resulting in successful registration. Currently, 2 applications are pending review.